CEN Biotech, Inc. (CENBF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 20, 2025, 4:00 PM EDT
CEN Biotech Market Cap
CEN Biotech has a market cap or net worth of $65.00 as of August 21, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
65.00
Enterprise Value
n/a
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 13, 2016, CEN Biotech's market cap has decreased from 13.86M to 65.00, a decrease of -100.00%. That is a compound annual growth rate of -74.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 65.00 | - |
| Dec 31, 2024 | 65.00 | -99.97% |
| Dec 29, 2023 | 195.77K | -92.64% |
| Dec 30, 2022 | 2.66M | -76.25% |
| Dec 31, 2021 | 11.20M | -19.16% |
| Sep 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |